Table 4 Prognostic factors from series considering unselected populations and related survivals

2008 [37]

58

Synchronous + metachronous

Overall: 16

No hepatic resection: 29.4%; 0%; 0%

Hepatic resection RFA: 75.3%; 31.7%; 20.8%

Ro resection

2009 [50]

72

Synchronous

NA

No hepatic resection: 36.4%; 0%; 0%

Hepatic resection (HAIC): 80%; 60%; 60%

H; P; R0 resection

2009 [51]

73

Metachronous

Overall: 7

BST: 5

Chemotherapy: 12

Hepatic resection: 23

BST: 22%; 2%; 0%

Chemotherapy: 45%; 6%; 0%

Hepatic resection; 81%; 20%; 20%

T; N; G of primary

R0 resection

2009 [52]

73

Synchronous

Stage of primary; H

Extrahepatic disease; treatment of mets

2010 [49]

Synchronous + metachronous

Overall: 16

Hepatic resection: 31.2

No hepatic resection: 53.2%; 4.2%; 0%

Hepatic resection: 82.3%; 46.4%; 37.1%